BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CDH1, uvomorulin, 999, P12830, ENSG00000039068, CDHE, Arc-1, UVO, LCAM, CD324, ECAD AND Prognosis
46 results:

  • 1. The Role of CPNE7 (Copine-7) in colorectal cancer prognosis and Metastasis.
    Kong HJ; Kang DH; Ahn TS; Kim KS; Kim TW; Lee SH; Lee DW; Ryu JS; Beak MJ
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069026
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identifying individualized prognostic signature and unraveling the molecular mechanism of recurrence in early-onset colorectal cancer.
    Yang J; Zhao Y; Yuan R; Wang Y; Wang S; Chang Z; Zhao W
    Eur J Med Res; 2023 Nov; 28(1):533. PubMed ID: 37986009
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Curcumol Reduces Aerobic Glycolysis and Overcomes Chemoresistance by Inducing cdh1-Mediated Skp2 Ubiquitination.
    Gan Y; Zhou L; Wang R; Zhang Y; Li X; Han S; Rong P; Wang W; Li W
    Am J Chin Med; 2023; 51(3):723-740. PubMed ID: 36866798
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. DNA Methylation and Gene Expression of the Cysteinyl Leukotriene Receptors as a Prognostic and Metastatic Factor for colorectal cancer Patients.
    Ghatak S; Satapathy SR; Sjölander A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834820
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. ARID1A downregulation promotes cell proliferation and migration of colon cancer via VIM activation and cdh1 suppression.
    Baldi S; Zhang Q; Zhang Z; Safi M; Khamgan H; Wu H; Zhang M; Qian Y; Gao Y; Shopit A; Al-Danakh A; Alradhi M; Al-Nusaif M; Zuo Y
    J Cell Mol Med; 2022 Dec; 26(24):5984-5997. PubMed ID: 36420658
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MACC1 promotes pancreatic cancer metastasis by interacting with the EMT regulator SNAI1.
    Zhang X; Luo Y; Cen Y; Qiu X; Li J; Jie M; Yang S; Qin S
    Cell Death Dis; 2022 Nov; 13(11):923. PubMed ID: 36333284
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Impact of neoadjuvant treatment on rectal gastrointestinal stromal tumors.
    Cheong C; Kang J; Min BS; Kim NK; Ahn JB; Lee KY
    PLoS One; 2022; 17(9):e0270887. PubMed ID: 36084094
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Predicting the Likelihood of colorectal cancer with Artificial Intelligence Tools Using Fourier Transform Infrared Signals Obtained from Tumor Samples.
    Villamanca JJ; Hermogino LJ; Ong KD; Paguia B; Abanilla L; Lim A; Angeles LM; Espiritu B; Isais M; Tomas RC; Albano PM
    Appl Spectrosc; 2022 Dec; 76(12):1412-1428. PubMed ID: 35821580
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Prognostic and tumor immunity implication of inflammatory bowel disease-associated genes in colorectal cancer.
    Wang D; Xie B
    Eur J Med Res; 2022 Jun; 27(1):91. PubMed ID: 35698180
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Molecular profiling of signet-ring-cell carcinoma (SRCC) from the stomach and colon reveals potential new therapeutic targets.
    Puccini A; Poorman K; Catalano F; Seeber A; Goldberg RM; Salem ME; Shields AF; Berger MD; Battaglin F; Tokunaga R; Naseem M; Zhang W; Philip PA; Marshall JL; Korn WM; Lenz HJ
    Oncogene; 2022 Jun; 41(26):3455-3460. PubMed ID: 35618879
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. New Perspectives on the Recurrent Monoallelic Germline Mutations of DNA Repair and Checkpoint Genes and Clinical Variability.
    Sahin I; Saat H
    Genet Test Mol Biomarkers; 2022 Jan; 26(1):17-25. PubMed ID: 35089076
    [No Abstract]    [Full Text] [Related]  

  • 12. MYSM1 inhibits human colorectal cancer tumorigenesis by activating miR-200 family members/cdh1 and blocking PI3K/AKT signaling.
    Chen X; Wang W; Li Y; Huo Y; Zhang H; Feng F; Xi W; Zhang T; Gao J; Yang F; Chen S; Yang A; Wang T
    J Exp Clin Cancer Res; 2021 Oct; 40(1):341. PubMed ID: 34706761
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Efficacy of 1 384 cases of peritoneal carcinomatosis underwent cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy].
    Yu Y; Li XB; Lin YL; Ma R; Ji ZH; Zhang YB; An SL; Liu G; Yang XJ; Li Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Mar; 24(3):230-239. PubMed ID: 34645167
    [No Abstract]    [Full Text] [Related]  

  • 14. Quantitative T2 Mapping to Discriminate Mucinous from Nonmucinous Adenocarcinoma in Rectal cancer: Comparison with Diffusion-weighted Imaging.
    Zhang J; Ge Y; Zhang H; Wang Z; Dou W; Hu S
    Magn Reson Med Sci; 2022 Oct; 21(4):593-598. PubMed ID: 34421090
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinicopathological and Molecular Characteristics of colorectal Signet Ring Cell Carcinoma: A Review.
    An Y; Zhou J; Lin G; Wu H; Cong L; Li Y; Qiu X; Shi W
    Pathol Oncol Res; 2021; 27():1609859. PubMed ID: 34381313
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Identified a disintegrin and metalloproteinase with thrombospondin motifs 6 serve as a novel gastric cancer prognostic biomarker by bioinformatics analysis.
    Zhu YZ; Liu Y; Liao XW; Luo SS
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33851708
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. cdh1 gene mutation in early-onset, colorectal signet-ring cell carcinoma.
    Aitchison A; Hakkaart C; Whitehead M; Khan S; Siddique S; Ahmed R; Frizelle FA; Keenan JI
    Pathol Res Pract; 2020 May; 216(5):152912. PubMed ID: 32147272
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. cdh1-mediated Skp2 degradation by dioscin reprogrammes aerobic glycolysis and inhibits colorectal cancer cells growth.
    Zhou L; Yu X; Li M; Gong G; Liu W; Li T; Zuo H; Li W; Gao F; Liu H
    EBioMedicine; 2020 Jan; 51():102570. PubMed ID: 31806563
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Scoring colorectal cancer risk with an artificial neural network based on self-reportable personal health data.
    Nartowt BJ; Hart GR; Roffman DA; Llor X; Ali I; Muhammad W; Liang Y; Deng J
    PLoS One; 2019; 14(8):e0221421. PubMed ID: 31437221
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Effect of Body Mass Index on 5-FU-Based Chemotherapy Toxicity and Efficacy Among Patients With Metastatic colorectal cancer; A Pooled Analysis of 5 Randomized Trials.
    Abdel-Rahman O
    Clin Colorectal Cancer; 2019 Dec; 18(4):e385-e393. PubMed ID: 31378656
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.